Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 7:42 PM
Ignite Modification Date:
2025-12-24 @ 7:42 PM
NCT ID:
NCT01304303
Brief Summary:
Phase I study of SPARC1023 alone and in combination with carboplatin
Detailed Description:
Pharmacokinetic profile and dose escalation study of SPARC1023 when administered as 30-min infusion.
Study:
NCT01304303
Study Brief:
Protocol Section:
NCT01304303